ORAGENICS INC financial data

Symbol
OGEN on NYSE
Location
Lakewood Ranch, FL
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 16 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 79% % -12%
Return On Equity -244% % 61%
Return On Assets -137% % 58%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4,336,029 shares -80%
Common Stock, Shares, Outstanding 4,271,529 shares 919%
Entity Public Float $3,126,135 USD -34%
Common Stock, Value, Issued $4,271 USD 919%
Weighted Average Number of Shares Outstanding, Basic 2,157,076 shares 877%
Weighted Average Number of Shares Outstanding, Diluted 2,157,076 shares 877%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $2,392,658 USD -42%
General and Administrative Expense $6,969,845 USD 8.2%
Operating Income (Loss) $9,362,503 USD 11%
Nonoperating Income (Expense) $616,894 USD -6677%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $10,334,078 USD 49%
Net Income (Loss) Attributable to Parent $9,842,487 USD 6.9%
Earnings Per Share, Basic -4.56 USD/shares 90%
Earnings Per Share, Diluted -4.56 USD/shares 90%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $4,399,726 USD 409%
Assets, Current $10,067,764 USD 584%
Assets $10,067,764 USD 584%
Accrued Liabilities, Current $202,834 USD -8.9%
Liabilities $1,786,359 USD 6.1%
Retained Earnings (Accumulated Deficit) $226,628,659 USD -4.5%
Stockholders' Equity Attributable to Parent $8,281,405 USD
Liabilities and Equity $10,067,764 USD 584%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $2,112,090 USD 31%
Net Cash Provided by (Used in) Financing Activities $4,668,328 USD 182%
Common Stock, Shares Authorized 350,000,000 shares 0%
Common Stock, Shares, Issued 4,271,529 shares 919%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $2,556,238 USD
Interest Paid, Excluding Capitalized Interest, Operating Activities $6,268 USD -12%
Deferred Tax Assets, Valuation Allowance $46,312,526 USD -4.2%
Deferred Tax Assets, Gross $46,312,526 USD -4.2%
Deferred Tax Assets, Operating Loss Carryforwards $40,114,803 USD -2.3%
Preferred Stock, Shares Issued 7,488,692 shares -56%
Preferred Stock, Shares Authorized 50,000,000 shares 0%
Unrecognized Tax Benefits $3,959,813 USD -2%
Additional Paid in Capital $234,905,793 USD 8.5%
Preferred Stock, Shares Outstanding 7,488,692 shares -56%
Share-based Payment Arrangement, Expense $516,049 USD -6.2%
Interest Expense $34,329 USD 126%